Azzad asks pharma companies to reassess drug pricing
Socially responsible investment firm joins interfaith coalition to make health care more affordable Falls Church, Va., 12/5/16 – Azzad Asset Management, investment advisor to the Azzad Funds, announced today that it has submitted drug pricing proposals to Merck & Co. and Gilead Sciences, two major pharmaceutical companies that manufacture some of America’s most popular prescription […]
2016 Year-End Financial Planning Basics
As we end the year, it’s time for some housekeeping tasks such as updating your beneficiary information for retirement accounts or other investment accounts. Plus, the window of opportunity for many tax-saving measures ends on December 31. There’s still time to affect your bottom line for the 2016 tax year, but you need to act […]
